- Home
- MNTK vs TKNO Comparison
MNTK vs TKNO Comparison
Compare MNTK & TKNO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MNTK
- TKNO
- Stock Information
- Founded
- MNTK 1980
- TKNO 1996
- Country
- MNTK United States
- TKNO United States
- Employees
- MNTK N/A
- TKNO N/A
- Industry
- MNTK Natural Gas Distribution
- TKNO Medicinal Chemicals and Botanical Products
- Sector
- MNTK Utilities
- TKNO Health Care
- Exchange
- MNTK Nasdaq
- TKNO Nasdaq
- Market Cap
- MNTK 306.2M
- TKNO 256.9M
- IPO Year
- MNTK 2021
- TKNO 2021
- Fundamental
- Price
- MNTK $2.07
- TKNO $4.36
- Analyst Decision
- MNTK Hold
- TKNO
- Analyst Count
- MNTK 3
- TKNO 0
- Target Price
- MNTK $3.33
- TKNO N/A
- AVG Volume (30 Days)
- MNTK 193.1K
- TKNO 185.8K
- Earning Date
- MNTK 08-06-2025
- TKNO 11-06-2025
- Dividend Yield
- MNTK N/A
- TKNO N/A
- EPS Growth
- MNTK N/A
- TKNO N/A
- EPS
- MNTK 0.02
- TKNO N/A
- Revenue
- MNTK $181,341,000.00
- TKNO $38,923,000.00
- Revenue This Year
- MNTK $3.74
- TKNO $9.52
- Revenue Next Year
- MNTK $3.88
- TKNO $15.20
- P/E Ratio
- MNTK $111.68
- TKNO N/A
- Revenue Growth
- MNTK N/A
- TKNO 11.40
- 52 Week Low
- MNTK $1.68
- TKNO $4.00
- 52 Week High
- MNTK $6.04
- TKNO $10.37
- Technical
- Relative Strength Index (RSI)
- MNTK 47.00
- TKNO 45.38
- Support Level
- MNTK $2.04
- TKNO $4.11
- Resistance Level
- MNTK $2.26
- TKNO $4.94
- Average True Range (ATR)
- MNTK 0.10
- TKNO 0.25
- MACD
- MNTK 0.00
- TKNO -0.01
- Stochastic Oscillator
- MNTK 33.33
- TKNO 30.95
About MNTK Montauk Renewables Inc.
Montauk Renewables Inc is a renewable energy company. It specializes in the recovery and processing of biogas from landfills and other non-fossil fuel sources for beneficial use as a replacement for fossil fuels. The firm develops, owns, and operates RNG projects that supply renewable fuel into the transportation and electrical power sectors. Montauk operates in two segments namely Renewable Natural Gas and Renewable Electricity Generation. It generates a majority of its revenue from the Renewable Natural Gas segment.
About TKNO Alpha Teknova Inc.
Alpha Teknova Inc provides critical reagents that enable the discovery, development, and production of biopharmaceutical products such as drug therapies, novel vaccines, and molecular diagnostics. Its offer three product types: pre-poured media plates for cell growth and cloning; liquid cell culture media and supplements for cellular expansion; and molecular biology reagents for sample manipulation, resuspension, and purification. It derives key revenue from United States.